Physician profile
Jonathan E Hullmann
NPI 1275996514
$2,561.10
in general payments reported to CMS, 2019-2025
25 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.10 · 2020: $34.15 · 2021: $87.31 · 2022: $671 · 2023: $792 · 2024: $822 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $474.51 | 2022-2024 | |
| Abbott Laboratories | $352.44 | 2022-2024 | Pressurewire, Coroflow |
| E.R. Squibb & Sons, L.L.C. | $301.36 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $227.96 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $189.33 | 2022-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $184.15 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $128.59 | 2022-2025 | Farxiga, Wainua, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.78 | 2023-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $99.38 | 2024-2025 | Opsumit, Uptravi |
| Pfizer INC. | $94.23 | 2020-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $52.34 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $38.90 | 2024-2025 | Nexletol |
| Amarin Pharma, INC. | $32.12 | 2022-2023 | |
| Atricure, INC. | $30.41 | 2023 | |
| Abiomed | $30.03 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.43 | 2023 | Injectafer |
| Boston Scientific Corporation | $27.19 | 2024 | Watchman Flx |
| Cardiva Medical, INC. | $22.10 | 2022 | |
| Philips North America LLC | $21.94 | 2019 | |
| Inspire Medical Systems, INC. | $20.45 | 2024 | Inspire |
| Scpharmaceuticals INC. | $18.08 | 2024 | |
| Cardiovascular Systems INC. | $17.76 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $16.10 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $15.36 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hullmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.